Pharmafile Logo
Pharmafocus logo
Advanced Search

Symeres appoints Gabriella Gentile as chief operating officer

October 13, 2025
Research and Development Symeres

Symeres, a mid-sized contract research, development and manufacturing organisation (CRDMO), has appointed Gabriella Gentile as its chief operating officer. Operating …

Appointment

Uterine fibroids and the cost of silence

October 9, 2025
Medical Communications, Research and Development Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …

Feature

Owen Mumford appoints Mark Glass as pharmaceutical services director

October 9, 2025
Owen Mumford

Owen Mumford, a developer and manufacturer of medical devices, has appointed Mark Glass as its new Director of Pharmaceutical Services. …

Appointment

Recipharm designates Germany site as Centre of Excellence

October 9, 2025
Research and Development CDMO, Cuxhaven, Recipharm, biologics

The multi-product facility recently underwent significant renovations

News
covid_cell

COVID-19 vaccine eligibility creates challenges for UK pharmacies

October 8, 2025
Medical Communications COVID-19, NHS, pharmacies, vaccinations

Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments despite no longer meeting the …

News

Celtic Renewables pushes for use of bio-based materials in pharma industry

October 8, 2025
Manufacturing and Production Celtic Renewables, Green Chemicals, sustainability

The company produces low-carbon, sustainable bio-based chemicals

News

Esaote presents new MRI system to support brain glioma surgeries

October 7, 2025
Research and Development Esaote, MRI, medical imaging, neurology

Gliomas are among the most common primary malignant brain tumours

News
drug-trials

Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits

October 6, 2025
Research and Development Bio-Rad, Diagnostics and Testing, Gencurix, oncology

The agreement expands access to oncology testing kits across Europe

News

Novel excipients: the key to unlocking drug innovation

October 6, 2025
Business Services Lubrizol, Pharmacy

ADVERTORIAL, IN ASSOCIATION WITH LUBRIZOL Meera Raghuram, Director of Regulatory and Sustainability Strategy at Lubrizol, explores how formulators can overcome …

Feature
Thought Leadership

The Pharma Files: With Colin Williams from Astellas Pharma

October 5, 2025
Medical Communications, Research and Development Astellas Pharma, Corporate, The Pharma Files, pm society

Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …

Feature

How can optichannel engagement drive return on investment across the product life cycle?

October 3, 2025
Business Services, Consultancy Corporate, PharmaForceIQ, Pharmacy, chief strategy officer, optichannel engagement

HCPs and patients are demanding personalised, streamlined experiences. Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ, discusses how optichannel engagement offers a …

Feature

Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness

October 3, 2025
Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

From sickness to prevention: the case for population health management

October 3, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

Feature

Micrima announces upcoming launch of new UK breast cancer assessment

October 3, 2025
Research and Development Micrima, breast cancer, oncology

Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …

News

Latham & Watkins appoints Lydia Torne as life sciences and IP partner

October 3, 2025
Latham & Watkins, intellectual property

Appointment brings specialist healthcare IP commercialisation expertise to the firm Latham & Watkins has appointed Lydia Torne as a partner …

Appointment

Veranova appoints Joe Torres-Ocasio as senior vice president and chief operating officer

October 2, 2025
Veranova, antibody-drug conjugates, appointment

Appointment follows significant investment into US manufacturing footprint Active pharmaceutical ingredient (API) manufacturer Veranova has appointed Joe Torres-Ocasio as senior …

Appointment

Pierre Fabre partners with Know Your Lemons Foundation for breast cancer awareness

October 2, 2025
Medical Communications Education, Pierre Fabre, breast cancer

The campaign focuses on early detection and education Pierre Fabre Laboratories has announced a partnership with the Know Your Lemons …

News
partnership

Nanoform partners with A&LS Pharma

October 2, 2025
Research and Development A&LS Pharma, Nanoform

Distribution agreement will make Nanoform’s products available in South Korea Nanoform Finland has entered into a distribution agreement with Ageing …

News

From Vaccine Innovation Pathway to growth powerhouse: how the UK is transforming clinical trials

October 2, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing 10 Year Health Plan, Life Sciences Sector Plan, NHS, National Institute for Health and Care Research, Pharmacy, UK Vaccine Innovation Pathway

Commercial clinical trials are a high-value growth driver for a country’s health and the economy and a key component of …

Feature
Thought Leadership

Five Facts about Breast Cancer

October 2, 2025
Medical Communications Breast Cancer Awareness Month, Five Facts, Oncology, breast cancer

1 There are striking inequities in breast cancer burden regarding the Human Development Index (HDI), the United Nation’s measure of …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025